Current and Emerging Treatment Regimens for HER2-Positive Breast Cancer.
Year: 2014
Type: article
Abstract: Overexpression of human epidermal growth factor receptor 2 (HER2) is an important factor in cancer survival, proliferation, and metastasis. Agents that target HER2-positive tumors are used with traditional chemotherapies, with other targeted therapies, or as monotherapy to treat metastatic breast cancers.
Source: Europe PMC (PubMed Central)
Author: Maribeth Maher
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W32497707